A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction 1 . A therapeutic ideal-relative to cell transplantation-would be to stimulate a resident source, thus avoiding the caveats of limited graft survival, restricted homing to the site of injury and host immune rejection. Here we demonstrate in mice that the adult heart contains a resident stem or progenitor cell population, which has the potential to contribute bona fide terminally differentiated cardiomyocytes after myocardial infarction. We reveal a novel genetic label of the activated adult progenitors via re-expression of a key embryonic epicardial gene, Wilm's tumour 1 (Wt1), through priming by thymosin b4, a peptide previously shown to restore vascular potential to adult epicardium-derived progenitor cells 2 with injury. Cumulative evidence indicates an epicardial origin of the progenitor population, and embryonic reprogramming results in the mobilization of this population and concomitant differentiation to give rise to de novo cardiomyocytes. Cell transplantation confirmed a progenitor source and chromosome painting of labelled donor cells revealed transdifferentiation to a myocyte fate in the absence of cell fusion. Derived cardiomyocytes are shown here to structurally and functionally integrate with resident muscle; as such, stimulation of this adult progenitor pool represents a significant step towards residentcell-based therapy in human ischaemic heart disease.
Two previous studies have indicated a significant contribution of embryonic epicardial progenitor cells (EPDCs) to the cardiomyocyte lineage 3, 4 . We investigated a basis for translating this myocardial potential in the adult heart. A significant problem in this regard is the lack of current adult epicardium-specific markers and authentic adult EPDCCre-expressing mouse strains for canonical lineage tracing. Previously reported genetic models to trace, or target, cells originating in the epicardium, such as Wt1
GFPCre/1 and Wt1
CreERT2/1
; R26R EYFP/1 mice or Tbx18
Cre mice 3, 4 , cannot be applied directly to their adult counterparts, as the epicardial markers are either restricted to embryonic stages ( Supplementary Fig. 1 ) or additionally expressed in the myocardium, as in the case of the Tbx18 model 5 . Therefore, we sought to reactivate Wt1 expression in the adult heart by pre-treatment ('priming') with thymosin b4 (Tb4), which we previously showed induces adult EPDCs to form vascular precursors for neovascularization 2, 6 , followed by myocardial infarction (see schematic, Fig. 1a ). Thus, we were able to establish both constitutive (GFP We initially established epicardial explants from Tb4-primed Wt1
GFPCre/1 adult hearts (7 days of intraperitoneal injections without myocardial infarction; Supplementary Fig. 2a-d cells, which expressed more mature markers of cardiomyocyte differentiation such as cardiac troponin T (cTnT, also known as Tnnt2; 4.1 6 1.6%; Supplementary Fig. 2i , j) sarcomeric a-actinin (SaA; 4.8 6 2.4%; Supplementary Fig. 2l , m) and cardiac myosin binding protein C (MyBPC, also known as Mybpc2; 4.6 6 0.8, mean percentage 6 s.e.m.; Supplementary Fig. 2o, p) . By day 14 in culture, cells adopted a more differentiated cardiac muscle phenotype; with evidence of sarcomeric structure in conjunction with compartmentalization of the GFP signal ( Supplementary Fig. 2k-r) .
Next we determined the extent of Wt1 re-expression in vivo alongside the quantity and distribution of GFP 1 and YFP 1 adult progenitors. With injury alone (no Tb4 priming), expression of Wt1 and Tbx18 was significantly increased at day 7 after myocardial infarction, dependent on the severity of the injury (Supplementary Fig. 3a) . Following Tb4 priming, expression of both epicardial genes was precociously increased by day 2 after myocardial infarction ( Supplementary Fig. 3b ), and this persisted in Tb4-primed GFP 1 cells isolated by fluorescence-activated cell sorting (FACS) at day 4 after injury ( Supplementary Fig. 4a ). In situ hybridization, at an equivalent stage, revealed an upregulation in Wt1 expression in small round 'progenitor-like' cells within the epicardium, subepicardial region and underlying myocardium (Supplementary Fig. 4b-d) .
Tb4 priming resulted in significantly more sorted GFP 1 and YFP 1 cells from whole hearts taken at day 7 after myocardial infarction when compared to treatment with vehicle ( Fig. 1b-e and Supplementary Fig.  5a -d; GFP, 6.12% 1Tb4 versus 3.38% 1PBS; YFP, 0.74% 1Tb4 versus 0.36% 1PBS). This was confirmed in situ by anti-GFP immunostaining on serial heart sections at the equivalent stage after injury ( Supplementary Fig. 5e ). Further flow cytometry characterization of a progenitor phenotype revealed that labelled cells, at day 4, were not c-Kit 1 ( Supplementary Fig. 6a-e) . Instead, approximately 80% were positive for stem cell antigen factor 1 (Sca-1 1 ; Supplementary Fig. 6f j), consistent with the notion that the adult epicardium is a heterogeneous lineage 12 . Two-photon molecular excitation laser scanning microscopy revealed pulse-labelled YFP 1 cells in the epicardium and subepicardial region at day 7 after myocardial infarction (Fig. 1f, g ), distributed in diminishing numbers towards the underlying myocardium (Fig. 1h) . Proliferative Ki67 1 progenitors were observed in epicardial and subepicardial regions ( Supplementary Fig. 7a , b) alongside YFP 1 cells positive for phospho-histone H3 ( Supplementary Fig. 7c-f ), which expanded in number from day 2-14 ( Supplementary Fig. 7g-m) . A subpopulation, residing in the epicardium, was positive for Isl1 and Nkx2-5 at day 2 after myocardial infarction (Fig. 1i-m and Supplementary Fig. 8a-d ) and these cardiac progenitors significantly increased by day 7 after myocardial infarction (Fig. 1n) . By day 14, YFP 1 cells were located within the border zone and peri-infarct region (Fig. 2a-c) , which co-expressed SaA (Fig. 2d , e, h-k) and cTnT (Fig. 2f,  g, l) and by virtue of their size, gross morphology and inherent ultrastructure resembled mature cardiomyocytes (Fig. 2d-l) . Whereas a relatively small number of Isl1 1 progenitors were evident in Tb4-primed, sham-operated hearts (Fig. 1n) , we failed to locate any mature GFP
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1 cardiomyocytes in the absence of injury (sham) or Tb4 priming (data not shown). The de novo cardiomyocytes appeared appropriately integrated with the resident myocardium and with each other, as determined by both N-cadherin (Ncad) 1 adherens junctions ( Fig. 2f-i ) and connexin 43 (Cx43) 1 gap junction formation (Fig. 2j,  k) . Structurally coupled mature cTnT 1 
1 cardiomyocytes were evident proximal to the scar and within the border zone (Fig. 2l) Supplementary  Fig. 9e-h ). The total mean percentage of YFP 1 progenitors that became cardiomyocytes was 0.59 6 0.18% (serial sections through n 5 7 hearts 6 s.e.m.). The mean ratio of YFP 1 de novo cardiomyocytes to YFP 2 pre-existing cardiomyoctes residing in the peri-infarct region (Fig. 2b) was 0.066 (1:15; 6 0.0015; six hearts analysed). In addition, from the two-photon imaging we were able to identify numbers of YFP 1 cardiomyocytes (192.5 6 12.1; four hearts analysed) in the underlying myocardium of the left ventricular wall up to a depth of #100 mm. Approximately 82% of YFP 1 cardiomyoctes were located proximal to the site of injury, residing within either the border zone or the immediate surrounding healthy myocardium (Fig. 2c , l and Supplementary Fig. 10a-c) .
To assess functional integration with resident myocardium, we recorded cellular calcium transients [Ca 21 ] i between YFP 1 and YFP 2 cells in situ, as previously described 13 ( Fig. 2m-s and Supplementary Fig. 10a-f) . Two-photon imaging confirmed migration of YFP 1 cells from the outer epicardial layer into the underlying myocardium ( Supplementary Fig. 7m ). At day 14 after myocardial infarction, evoked [Ca 21 ] i transients in YFP 1 cardiomyocytes were synchronous, with kinetics indistinguishable from those of neighbouring YFP 2 cardiomyocytes (Fig. 2q-s) . Apparent differences in resolution between resident YFP 2 and de novo YFP 1 cardiomyocyte transients (compare Fig. 2q with r) were observed, reflecting the newly acquired function of the YFP 1 population. To rule out the possibility that we traced resident cardiomyocytes that were labelled by virtue of ectopic activation of the fluorophore from the Wt1 knock-in alleles, we carried out a series of experiments transplanting FACS-isolated donor GFP 1 cells into non-transgenic host hearts. Extensive analyses indicated that the prospective donor cells were progenitors of epicardial origin (Fig. 3) . Wt1 1 cells were restricted to the epicardium and subepicardial region throughout the heart, as confirmed by co-staining with an antibody against podoplanin, a transmembrane glycoprotein 14 that specifically marked the 1 cells that co-stained for Isl1 (highlighted by white arrowheads in k) resided in the epicardium proximal to areas of scarred myocardium 2 days (d2) after myocardial infarction. sc, scar region. Scale bar in l (also applies to i-l), 50 mm. m, Significant increase in Isl1 expression in primed hearts at days 2, 4 and 7 after myocardial infarction relative to sham-operated controls *P # 0.05, **P # 0.01, ***P # 0.001; MI group 1 and group 2 versus sham; myocardial infarction categories: purple, mild injury; cream, severe injury; n 5 6 hearts per sham and MI groups. n, Significant increases in Isl1
1
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1 cells at days 2 (*P # 0.05), 4 (**P # 0.01) and 7 (***P # 0.001) after myocardial infarction and Nkx2-5
1
/YFP
1 cells by day 7 (***P # 0.001) alongside phospho-histone H3 1 (P-HH3
1
) proliferating YFP 1 progenitors at day 7 (***P # 0.001), compared to sham-operated controls. P values were calculated by Student's t-test (m) and paired ANOVA (n). Error bars represent mean 6 s.e.m. N values are numbers of hearts analysed for each group: N 5 3 (m); N 5 4 (d2 and d4) and N 5 7 (d7) (n).
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epicardial and myocardial boundaries (Fig. 3a, b) . Immunostaining for anti-GFP revealed GFP 1 cells residing in the expanded epicardium but excluded from the myocardium throughout the heart (Fig. 3c, e) . Real-time quantitative polymerase chain reaction analyses on FACS-isolated donor cells at day 4 revealed no expression of the canonical cardiomyocyte markers cTnT, MyBPC and Actn2 (Fig. 3d) . We also analysed hearts isolated from Tb4-primed/injured
MLC2v
Cre/1 ;R26R EYFP/1 mice (MLC2v-YFP; Fig. 3f ), which lineagetraced ventricular cardiomyocytes as YFP 1 from early developmental stages 15 to adulthood, and confirmed an absence of Wt1 in both healthy and scarred myocardium respectively (Fig. 3g, h) .
In a previous study, Wt1 was shown to be expressed in the coronary vasculature after myocardial infarction in the rat heart 16 . Co-immunostaining for Wt1 or GFP with Pecam and Flk1, respectively, excluded Wt1 expression in both coronary veins and arteries within the donor 
/GFP
1 cells at day 4 after myocardial infarction seem to be derived from epicardium. a, b, Immunostaining for Wt1 and anti-podoplanin (PDPN) revealed that the day 4 donor Wt1 1 cells were restricted to the epicardium and subepicardial space. ep, epicardium; my, myocardium; sc, scar; ses, subepicardial space. c, e, Anti-GFP and anti-cTnI costaining revealed spatial restriction to the equivalent epicardial regions as for Wt1 staining with exclusion from the myocardium. d, cTnT, MyBPC and Actn2 were not expressed in the FACS GFP 1 population at day 4 after myocardial infarction, whereas expression of all three myocardial markers was significantly upregulated in GFP 1 cells at day 14 consistent with contribution of de novo cardiomyocytes. f-h, Wt1 1 cells were restricted to the epicardium and excluded from MLC2v-YFP 1 ventricular cardiomyocytes in regions of healthy (g) and scarred (h) myocardium. i-k, Expression of Wt1/GFP was excluded from within the Pecam
1
/Flk1
1 coronary vasculature (i, j; cv, coronary vein; ca, coronary artery) and confirmed by a lack of expression of Pecam and Tie2 in the day 4 GFP 1 FACS population (k). l, m, Cytospin/ immunostaining revealed a homogeneous GFP 1 fraction at day 4, without contamination from GFP 2 cells (l), which lacked vascular (Pecam and SMA) and myocardial (SaA, cTnT) markers (m) as compared to the GFP 2 fraction (n). *P # 0.05, **P # 0.01, all statistics by Students t-test. Error bars represent mean 6 s.e.m., N values are numbers of hearts analysed for each group: N 5 6 (day 4) and N 5 7 (day 14) (d); N 5 6 (k). All scale bars are 50 mm, except a, e, 500 mm; f, 200 mm; m, n, 20 mm. (Fig. 3i, j) . The FACS-isolated cells at day 4 revealed no expression of the canonical vascular markers Pecam and Tie2 (Fig. 3k) , and cytospin with comparative immunostaining of the sorted GFP 1 and GFP 2 populations (Fig. 3l) revealed that the GFP 1 cells were negative for both vascular markers Pecam and SMA and myocardial markers SaA and cTnT (Fig. 3m) , whereas the GFP 2 population contained cardiovascular cells (Fig. 3n ). After donor cell transplantation (Fig. 4a) , GFP 1 cells within the epicardial region of the host were restricted to the site of injection after 24 h (Fig. 4b) . By day 7, GFP 1 /Nkx2-5 1 donor cells, indicative of myocardial progenitor commitment, were located proximal to the subepicardium (Fig. 4c) , in conjunction with morphologically immature, cTnT 1 cardiomyocyte-like cells (Fig. 4d) . Collectively, the presence of these staged donor derivatives suggested progressive differentiation towards a mature cardiomyocyte fate. More definitive donor GFP 1 cardiomyocytes with myofibrillar structure and that co-expressed cTnT were observed residing within the host myocardium at day 14 ( Fig. 4e, f) . We subsequently traced donor GFP 1 cardiomyocytes for fluorescent in situ hybridization (FISH) with X-and Y-chromosome paints to assess karyotype (Fig. 4a) . Single XY GFP 1 cardiomyocytes were detected within the XX host, indicating that transdifferentiation had occurred in the absence of cell fusion (predicted XYXX fusion karyotype; Fig. 4g-j) . To exclude the possibility of reductive divisions of fusion hybrids accounting for the XY diploid karyotype, reciprocal transplantation experiments injecting female XX GFP 1 donor cells into male XY wild-type hosts (Fig. 4k ) resulted in XX GFP 1 /SaA 1 cardiomyocytes (Fig. 4l, m) in XY host myocardium (Fig. 4n, o) . Quantitative assessment of FISH on GFP 1 cardiomyocytes (total n 5 22) excluded the presence of a host Y chromosome in each case. Finally, we reanalysed non-transplanted YFP 1 cells in female hearts (see Fig. 2 ) and detected examples of both YFP Fig. 4r) cardiomyocytes with a single XX karyotype (Fig. 4q, s) .
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To investigate the outcome of Tb4 priming on cardiac function and myocardial regeneration, we carried out serial magnetic resonance imaging (MRI) 7, 14 and 28 days after myocardial infarction (Supplementary Fig. 11a-e Supplementary Fig.  11f, g ).
Collectively, these data indicate that the adult heart can respond to injury with a modest increase in Wt1 1 progenitors but without initiating a cardiogenic program. Tb4 enhances this response, via a precocious and significant reactivation of Wt1 expression ultimately resulting in cardiomyocyte restitution. Although we cannot unequivocally exclude the possibility that Wt1 1 progenitors arise from a nonepicardial source, support for an adult EPDC myocardial contribution comes from the tight regulation of Wt1 1 labelling in the epicardium and subepicardial region, and transplantation of donor GFP 1 progenitors residing both within and immediately proximal to the epicardium.
Reactivation of Wt1 by injury and Tb4 represents a robust means to faithfully tag the progression of adult cardiac progenitors to differentiated myocytes, and provides mechanistic insight into a molecular function of Tb4 and downstream cellular events. Previously, Tb4 was shown to upregulate ILK and Akt activity in the heart, enhancing early myocyte survival after ischaemic injury 17 . In addition, Tb4 can induce the adult epicardium, in the same setting, to contribute coronary endothelial and smooth muscle cells and initiate vascular repair 6, 18 . We now propose a further contribution, underpinning the initiation and migration of resident cardiovascular progenitors towards a cardiomyocyte fate. Although in the current study it is not possible to discriminate the relative contribution of each these proposed functions, several effects of Tb4 seem to be delineated with time post-myocardial Fig. 3 ), had an XX karyotype (white box insets) supporting transdifferentiation in the absence of cell fusion with resident cardiomyocytes (q, s). Scale bars: c, 25mm; d-f, 20 mm; g (applies to g-j), k (applies to k-o), p (applies to p-q), r (applies to r-s), 10 mm.
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infarction. The pro-survival activity of Tb4 is an early injury response to maintain the status quo of surviving myocardium, whereas the neovascularization and de novo cardiogenesis are longer-term regenerative functions potentially acting through the common target of adult EPDCs.
The identification of a bona fide source of myocardial progenitors is a significant step towards resident-cell-based therapy for acute myocardial infarction in human patients. The induced differentiation of the progenitor pool described into cardiomyocytes by Tb4 is at present an inefficient process relative to the activated progenitor population as a whole. Consequently, the search is on via chemical and genetic screens to identify efficacious small molecules and other trophic factors to underpin optimal progenitor activation and replacement of destroyed myocardium. GFPCre/1 mice were differentiated for 14 days in IMDM plus 20% FBS and fixed in 4% paraformaldehyde. Permanent left anterior descending artery (LAD) ligation was performed in adult Wt1
METHODS SUMMARY
GFPCre/1 (n 5 85, sham n 5 6), Wt1
;R26R
EYFP/1 (n 5 31, sham n 5 6), MLC2v-YFP (n 5 5), wild-type transplantation hosts (n 5 5 females; n 5 6 males) and wild-type C57BL/6J mice (n 5 21). Tb4 or vehicle was given on alternate days post-myocardial infarction. Two-hundred microlitres of BrdU labelling reagent (Invitrogen) was injected at days 0, 2 and 4. Hearts were digested with 0.1% collagenase II, GFP 1 /EYFP 1 cells quantified (Beckman Coulter MoFlo XDP) and c-Kit and Sca-1 expression determined (Beckman Coulter CyAn ADP). Cytospins were collected using a Shandon Cytospin 3 centrifuge. Immunofluorescence analysis was performed on EPDC cultures, cytospun FACS-sorted cells and post-myocardial-infarction heart cryosections. Total RNA was isolated from myocardial infarction heart apex and from FACS-sorted GFP 1 cells and reverse transcribed for real-time qRT-PCR using SYBR Green on an ABI 7900 with Hprt as endogenous control. Fold-change was determined by the 2 2DDCT method and presented relative to levels in sham hearts. Multiphoton imaging was performed on Langendorff perfused hearts loaded with rhod-2/AM as described 19 . Spontaneous calcium transients, visualized without electrical pacing, were calculated using ImageJ. MRI analysis was performed on Wt1
CreERT2/1 ;R26R EYFP/1 and wild-type C57BL/6J mice, treated with Tb4 or vehicle, 7, 14 and 28 days postmyocardial infarction, to determine temporal changes in infarct size and cardiac function. For transplantation experiments 3-6 3 10 4 FACS-sorted GFP 1 cells were injected under the epicardium of sex mismatched, LAD-ligated, Tb4-treated mice. Hearts harvested at 24 h, 7 days and 14 days were processed for immunofluorescence and FISH.
All animal experiments were carried out according to UK Home Office project licence PPL 70/6691 compliant with the UK Animals (Scientific Procedures) Act 1986 and approved by the University College London Biological Services Ethical Review Process.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Generation of epicardial trace mice. Wt1
GFPCre/1 mice have been previously described 4 . Inducible Wt1
CreERT2/1 ;R26R EYFP/1 mice were generated by crossing the Wt1
CreERT2/1 strain with Rosa26R EYFP/1 reporter mice and genotyping as previously described. Adult mice were primed with intraperitoneal (i.p.) injection of Tb4 or vehicle (PBS) into either Wt1
GFPCre/1 or Wt1 ). Half of each myocardial infarction group were pretreated with Tb4 and half were vehicle treated (n 5 6 sham-operated controls were included per experiment). Hearts were subsequently assessed using a combination of FACS, cytospin, immunofluorescence and real-time qRT-PCR analyses for GFP/YFP expression and myocardial markers after 2, 4, 7 and 14 days (see schematic in Fig. 1a) . With respect to monitoring progenitor-derived cardiomyocytes the focus was on the inducible Wt1
CreERT2/1 ;R26R EYFP/1 model to ensure specific temporal labelling of YFP 1 derivatives and rule out ectopic activation of the Wt1 gene at the targeted allele. Mice that were PBS treated with tamoxifen and Tb4 primed in the absence of tamoxifen were used as controls and importantly we never observed YFP 1 cardiomyocyte-like cells in these hearts.
Generation of MLC2v
Cre/1 ; R26R EYFP/1 mice. MLC2v Cre/1 mice have been described previously 15 and were crossed with the R26R EYFP/1 strain to generate MLC2v-YFP mice for myocardial infarction and to exclude Wt1 upregulation in YFP 1 cardiomyocytes. Adult epicardial explant cultures. Adult EPDCs were prepared, as previously described 7 , from 8-10-week-old Wt1
GFPCre/1 mice that had received daily i.p. injections of Tb4 (RegeneRX, 12 mg kg 21 in PBS) or vehicle (PBS) for 7 days. Cells were allowed to differentiate for up to 14 days in Iscove's modified Dulbecco's medium (IMDM) containing 20% FBS, before fixing in 4% paraformaldehyde for immunostaining analysis. At the outset GFP 1 cells were recorded emerging from Tb4-treated explants (66.8 6 4.5; mean percentage of GFP 1 cells relative to total number of cells in outgrowth 6 s.e.m.; n 5 12 explants). Outgrowing cells, up to 6 days in culture, were documented as immature and phenotypically similar to Nkx2-5 1 progenitors previously isolated from embryonic hearts 10 ( Supplementary Fig. 2a-d ). Throughout the ex vivo studies, PBS (vehicle)-treated explants were used as controls and revealed limited outgrowth or emergence of a significantly reduced number of GFP 1 progenitor-like cells. The percentage incidence of GFP 1 progenitors in the PBS treated/control explant cultures was recorded as 14.3 6 1.9% (mean 6 s.e.m.; n 5 12), significantly lower (P # 0.001) than those primed by Tb4. Importantly, vehicle-treated cells failed to adopt a myocardial fate and only isolated fibroblast-derivatives were observed in control cultures (not shown).
Despite evidence of sarcomeric marker expression (cTnT, SaA and MyBPC) after Tb4 treatment we did not observe beating in culture of the more differentiated cardiomyocyte-like cells documented. Because spontaneous contraction in vitro is confined to immature fetal or neonatal cardiomyocytes 20 , this may reflect a more mature adult myocyte phenotype. Tb4 administration. The injection regimen of Tb4 for priming Wt1
CreERT2/1 ;R26R EYFP/1 mice, including induction with tamoxifen is outlined in Fig. 1a . In separate experiments, MLC2v
Cre/1 ;R26R EYFP/1 and wild-type C57BL/ 6J mice were subject to the same injection regimen for epicardial priming. Adult mice received i.p. injection of Tb4 (12 mg kg ;R26R EYFP/1 mice were injected with tamoxifen (2 mg suspended in peanut oil; i.p.) to induce CreERT2/Cre expression. Further injections of Tb4/vehicle were given on day 9 and tamoxifen on day 10. Myocardial infarction was performed 3 days after this regimen. Myocardial infarction. Mice were housed and maintained in a controlled environment. All surgical and pharmacological procedures were performed in accordance with the Animals (Scientific Procedures) Act 1986, (Home Office, UK). For all experiments adult male Wt1
GFPCre/1 (n 5 85), Wt1
CreERT2/1 ;R26R EYFP/1 (n 5 31), MLC2v
Cre/1 R26R EYFP/2 mice (n 5 5) and wild-type C57BL/6J mice (n 5 21), (25-30 g) were primed with Tb4 or vehicle, as described earlier, before surgical procedures. Myocardial infarction was induced in isoflurane-anaesthetized mice by permanent ligation of the left anterior descending artery (LAD). Sham controls (suture passed under the LAD but not ligated) were performed in Wt1
GFPCre/1 mice (n 5 6) and Wt1 ;R26R EYFP/1 mice were injected i.p. with 200 ml of BrdU labelling reagent (Zymed, Invitrogen) on recovery and at 2 and 4 days after LAD ligation. Hearts were harvested at 2, 4, 7 and 14 days after ligation and bisected transversely midway through the scar: the apex was snap frozen for RNA isolation and subsequent real-time qRT-PCR studies while the remaining tissue was fixed in 4% PFA for cryosectioning and immunostaining analyses.
GFP
1 /YFP 1 cell isolation and characterization. Hearts from Wt1 GFPCre/1 and Wt1
CreERT2/1 ;R26R EYFP/1 mice treated with Tb4 or vehicle were harvested 7 days after ligation and processed by enzymatic digestion using a 0.1% collagenase II-PBS solution (Worthington Biochemicals) to achieve a single-cell suspension. GFP 1 or EYFP 1 cells were isolated from the total cardiac cell population using a Beckman Coulter MoFlo XDP cell sorter with a 488 nm laser beam to excite YFP/ GFP (collected in the 530/40 nm channel) and a 355 nm laser beam used to excite DAPI (collected in the 450/50 nm channel).
To characterize GFP 1 cells, hearts from Wt1 GFPCre/1 mice treated with Tb4 were harvested 4 days after ligation and processed, as described earlier, to obtain a single-cell suspension. As a control, hearts from uninjured Wt1
GFPCre/1 mice treated either with Tb4 or with vehicle were also analysed after 7 days. Cells were incubated with the following primary and secondary antibodies: c-Kit (goat IgG, R&D System), Sca-1 (rat IgG2a, BD Pharmigen), Alexa Fluor 647 anti-goat or Alexa Fluor 647 anti-rat (Invitrogen) and analysed using a Beckman Coulter CyAn ADP analyser equipped with a 488 nm laser and 633 nm red diode and run by Summit Software. Data were analysed using the FlowJo Software.
Cell cytospins were collected using a Shandon Cytospin 3 centrifuge. Cytospun cells were then processed for immunostaining for epicardial and cardiovascular markers as described earlier.
YFP 1 cardiomyocytes were assessed by cell counts through serial sections. The mean percentage of YFP 1 progenitors that became cardiomyocytes was estimated across n 5 7 hearts 6 s.e.m. The incidence of YFP 1 de novo cardiomyocytes relative to pre-existing myocardium was expressed as the mean ratio of YFP 1 cells divided by YFP 2 cells across serial sections per heart 6 s.e.m. (n 5 6 hearts analysed). Cell counts were also assessed after two-photon imaging in Langendorff-perfused hearts and expressed as the mean number of YFP 1 cardiomyocytes per heart 6 s.e.m. (n 5 4 hearts analysed). Immunodetection methods. Immunofluorescence was performed on adult epicardial explant cultures, on cytospun FACS-sorted cells and on cryosections of post-myocardial infarction hearts using standard protocols with the following antibodies: GFP (Clontech and Abcam, which also detect EYFP), SaA (Sigma), cardiac MyBPC (a gift from E. Ehler and M. Gautel), cTnT, cTNI, BrdU, Isl1 and Wt1 (all Abcam), Nkx2-5 (Santa Cruz), phospho-histone H3 (Upstate), podoplanin (Fitzgerald Industries) and Ki67 (Dako). To rule out the possibility of autofluorescence accounting for the detection of either GFP or YFP protein expression, sections through the left ventricle were stained with a polyclonal anti-GFP antibody (which detects both fluorescent proteins). The specificity of the anti-GFP antibody was ascertained by immunofluorescence on non-primed, intact hearts, which detected neither labelled cells in the epicardial region, nor their derivatives (no signal; not shown).
To detect BrdU-positive nuclei, sections were treated with 2 N HCl for 30 min at room temperature (22 uC) to denature the DNA, and neutralized in 0.1 M sodium borate pH 8.5 for 12 min before incubation with the anti-BrdU antibody. Owing to the destruction of cellular antigens resulting from acid treatment, these steps were performed after the incubation with antibodies to GFP and SaA. Images were acquired using either a Zeiss AxioImager with ApoTome or a Zeiss LSM 710 confocal microscope equipped with argon and helium neon lasers using 320, 340 and 363/1.4 (oil immersion) objectives. RNA in situ hybridization. RNA in situ hybridization on adult heart cryosections was performed as previously described 21 , using a digoxigenin-labelled antisense riboprobe specific for Wt1 (ref. 4) , alongside a sense control. RNA isolation and gene expression profiling. Total RNA was isolated from the apex of collected hearts using the Trizol reagent (Invitrogen), according to the manufacturer's instructions and reverse-transcribed using Superscript III RT (Invitrogen). Real-time qRT-PCR analysis was performed on an ABI 7900 Sequence Detector (Applied Biosystems) using SYBR Green (QuantitectTM SYBR Green PCR Kit, Qiagen). Data were normalized to Hprt expression (endogenous control). Fold-changes in gene expression were determined by the 2 2DDCT method 22 and are presented relative to levels in non-myocardial infarction (sham) hearts. Complementary DNA PCR primer sequences were obtained from Primer Bank (http://pga.mgh.harvard.edu/primerbank/) and details are available on request.
To characterize GFP 1 progenitors, total RNA was obtained from FACS-sorted GFP 1 cells isolated after enzymatic digestion of the hearts of the Tb4-treated Wt1
GFPCre/1 mice at 4 and 14 days following LAD ligation using a Beckman Coulter MoFlo XDP cell sorter. Total RNA was isolated using the RNeasy Micro Kit (Qiagen), according to the manufacturer's instructions, and processed as above. Multiphoton imaging. Multiphoton imaging was performed in Langendorffperfused hearts loaded with Rhod-2/AM (Invitrogen) as described previously 19 except that 50 mM blebbistatin was used to inhibit myosin crossbridge cycling and prevent movement. Spontaneous calcium transients were visualized without LETTER RESEARCH
